Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study

Two doses of mRNA SARS-CoV-2 vaccines elicit an attenuated humoral immune response among immunocompromised patients. Our study aimed to assess the immunogenicity of a third dose of the BNT162b2 vaccine among lung transplant recipients (LTRs). We prospectively evaluated the humoral response by measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Shostak, Yael, Kramer, Mordechai R., Edni, Omer, Glusman Bendersky, Ahinoam, Shafran, Noa, Bakal, Ilana, Heching, Moshe, Rosengarten, Dror, Shitenberg, Dorit, Amor, Shay M., Ben Zvi, Haim, Pertzov, Barak, Cohen, Hila, Rotem, Shahar, Elia, Uri, Chitlaru, Theodor, Erez, Noam, Peysakhovich, Yuri, D. Barac, Yaron, Shlomai, Amir, Bar-Haim, Erez, Shtraichman, Osnat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141618/
https://www.ncbi.nlm.nih.gov/pubmed/37112711
http://dx.doi.org/10.3390/vaccines11040799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141618/
https://www.ncbi.nlm.nih.gov/pubmed/37112711
http://dx.doi.org/10.3390/vaccines11040799

Ejemplares similares